| scholarly article | Q13442814 |
| P2093 | author name string | Jun Li | |
| Yasuyuki Ishii | |||
| Omar Duramad | |||
| Amy Laysang | |||
| Reiko Namikawa | |||
| P433 | issue | 8 | |
| P921 | main subject | leukemia | Q29496 |
| murine model | Q122890741 | ||
| P304 | page(s) | 1154-1168 | |
| P577 | publication date | 2010-12-08 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models | |
| P478 | volume | 17 |
| Q54937398 | Advance in Targeted Immunotherapy for Graft-Versus-Host Disease. |
| Q34790016 | CCR7 expressing mesenchymal stem cells potently inhibit graft-versus-host disease by spoiling the fourth supplemental Billingham's tenet |
| Q53661346 | Clonal Deletion Established via Invariant NKT Cell Activation and Costimulatory Blockade Requires In Vivo Expansion of Regulatory T Cells. |
| Q34806652 | Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells |
| Q89413287 | High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg |
| Q58415034 | Immune Regulation in Hematopoietic Cell Transplantation |
| Q42175189 | Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells |
| Q38616695 | Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation |
| Q43555934 | Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies |
| Q38734173 | Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression. |
| Q55003489 | Nanoparticles in the clinic. |
| Q42365163 | PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients |
| Q90745772 | Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease |
| Q36462109 | Regulatory T Cell Immunotherapy in Immune-Mediated Diseases |
| Q37272005 | Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation |
| Q38095964 | Regulatory T-cell immunotherapy for allogeneic hematopoietic stem-cell transplantation |
| Q42203147 | Systemic inflammatory response elicited by superantigen destabilizes T regulatory cells, rendering them ineffective during toxic shock syndrome |
| Q38117369 | The role of regulatory T cells in the biology of graft versus host disease. |
| Q48306919 | iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model |
Search more.